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ABSTRACT 
Objective: The aim of the present study was to investigate the effect of novel polymeric carriers and to develop solid dispersion formulation that 
could improve in vitro profile of Fenofibrate (FB).  
Methods: Spray drying technique was used to fabricate solid dispersions with hydrophilic carriers, mainly hydroxypropyl methylcellulose (HPMC) and 
hydroxypropyl methylcellulose acetate succinate (HPMCAS). Solid dispersions in the form of spray-dried powder were characterized with respect to the 
pure drug and the corresponding physical mixtures by optical microscopy, x-ray diffraction (XRD), fourier transform infrared (FT-IR) spectroscopy and 
differential scanning calorimetry (DSC). Size and morphology of optimized solid dispersion were performed by scanning electron microscopy (SEM). 
Furthermore, in vitro dissolution comparisons were carried out between the optimized solid dispersion against the pure drug and the physical mixtures. 
Results: Solubility studies demonstrated that the solubility of FB was not affected by pH change. The transformation of crystalline FB into an 
amorphous solid dispersion powder has been clearly demonstrated by optical microscopy. The molecular dispersion of drug in the dispersion 
matrix prepared by spray drying was confirmed in XRD and DSC studies. IR spectroscopy was observed with negligible incompatibility of the drug 
with polymers. Spherical morphology was observed in SEM with no evidence of FB crystals. The prepared solid dispersions exhibited dissolution 
improvement as compared to the pure drug and spray dried FB in 0.05 M SLS, with HPMCAS as the superior carrier over HPMC. 
Conclusion: The present study vouches better in vitro profile of FB from spray-dried HPMCAS based solid dispersions.  
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About 40% of New Chemical Entities in drug development pipelines 
suffered from poor water solubility or dissolution rate-limited 
absorption which eventually falls into the Biopharmaceutics 
Classification System (BCS) Class II and thus they fail to reach the 
market. These poorly water-soluble drugs are associated with slow 
drug absorption leading to inadequate and variable bioavailability 
and gastrointestinal mucosal toxicity [1]. Techniques have been 
developed to address the low aqueous solubility challenges, 
including chemical modification, such as pro-drugs and salt 
formation, or formulation methods such as particle size reduction, 
co-crystal formation, inclusion complexes using cyclodextrins and 
lipid formulations and solid form changes such as nanocrystals and 
amorphous dispersions of API and polymers [2]. Of these 
techniques, amorphous solid dispersion is a useful approach to 
increase the dissolution rate of poorly water-soluble drugs and 
thereby improve their bioavailability, although this must be proved 
for each drug. The preparation of the solid dispersion involves drug 
deposition on the surface of an inert carrier which results in a 
greater surface area of the drug leading to a faster rate of dissolution 
[3]. Recently used methods for the preparation of amorphous solid 
dispersions include mechanical grinding, melting, hot melt 
extrusion, spray drying, lyophilization and supercritical fluid 
precipitation [4]. Spray drying is one of the effective methods for 
preparing amorphous solid dispersion which consists of suspending 
the drug and the polymer in a common solvent and then drying it to 
form uniform nanoparticulate size powder [5]. The scalability and 
efficient critical process parameters of spray drying technology 
based solid dispersions are widely applied in the pharmaceutical 
industry, which provides equalized content uniformity and 
nanosized distributed solid surfaces. 
FB, a prodrug of fenofibric acid, is used for the treatment of 
hypertriglyceridemia, mixed dyslipidemia, and hyper-
cholesterolemia, as it can reduce levels of triglycerides, total 
cholesterol and low-density lipoprotein [6]. However, FB is a neutral 
lipophilic drug (log P = 5.2), which is practically insoluble in water. It 
is classified as a class II BCS drug and oral bioavailability of 
approximately 30% is reported in humans. Many nanoformulations 
like mesoporous solid particles, liposomes or tablet approaches have 
been studied to improve the solubility of FB. However, the majority 
of these formulations used either a special matrix of mesoporous 
surfaces, superdisintegrants or surfactants as modified excipients 
lacking long-term biocompatibility or involved technically 
challenging processes. Some reports have confirmed that silica can 
act as an immunogenic sensitizer and induce contact 
hypersensitivity. Furthermore, the formulation must be carefully 
designed because the pore architecture of silica may greatly 
influence its biocompatibility, and high dose and long-term usage 
should be avoided [5, 6]. The spray drying technique used for the 
preparation of the solid dispersion using different hydrophilic 
polymers such as HPMC and HPMCAS has not been explored to 
improve the aqueous solubility of FB. In the present study, an 
attempt was made to develop and optimize a solid dispersion 
system using different proportions of drug per carrier. Furthermore, 
the present study aims to clarify the potential for improving the 
solubility and dissolution rate of FB using hydrophilic polymers such 
as HPMC and HPMCAS by spray drying technology. 
MATERIALS AND METHODS 
HPMCAS-LF and HPMC (K100 Grade) were obtained from signet 
chemicals corporation, Mumbai. FB was procured from macleod’s 
pharmaceuticals, Mumbai. HPLC grade acetonitrile, hydrochloric 
acid (HCl), and dichloromethane were purchased from SD fine 
chemicals llimited, India. Methanol and potassium dihydrogen 
phosphate were purchased from rankem India. Phosphoric acid was 
purchased from fischer scientific limited, India. All chemicals and 
reagents utilized were of analytical grade. Triple distilled water 
(Rions, India) was used throughout the entire study.  
High-performance liquid chromatography (HPLC) analysis of FB 
Reversed-phase column based high-performance liquid 
chromatographic method (Nexera X2, Shimadzu, Japan) was used for 
quantification of FB in analytical media. The LC system consisted of a 
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pump configured to Lab Solutions software with auto-injecting 
facility. The HPLC was equipped with a column oven and the 
analytical column used was Enable C-18; 4.6 mm × 250 mm; 5 µm in 
diameter with an injection loop of 20 µl. The mobile phase used was 
acetonitrile and acidified water (pH of water adjusted with 
phosphoric acid to 2.5±0.1) (70:30) at a flow rate of 1 ml/min. The 
injection volume was 5 µl with a run time of 20 min and the drug 
peak was observed at 286 nm through photodiode array (PDA) 
detector. Column equilibration was done at least 30 min prior to the 
injection of the drug solution [7]. 
Solubility determination in different media 
Equilibrium solubility of FB was determined at 37±1 °C under 
physiological pH conditions i.e. 0.1 N HCl, phosphate buffer (PB) pH 
4.5, pH 6.8 and in different media such as distilled water and sodium 
lauryl sulphate (SLS) 25 mmol and 0.05M using validated shake flask 
method [8]. An excess amount of drug i.e. 10 mg of FB was added to 
glass vials containing 5 ml of each medium and allowed to 
equilibrate for 24 h. The content of each vial was filtered through a 
0.22 µm membrane filter (Millipore, India) and was analyzed using 
HPLC.  
Preparation of binary systems 
Preparation of HPMC and HPMCAS physical mixtures of FB 
For the preparation of physical mixtures, FB and polymers were 
added in different ratios (2:1, 1:1 and 1:2) and were mixed 
thoroughly with the help of pestle-mortar to obtain homogeneous 
mixtures (table 1). The resulting mixture was passed through sieve 
#40 and was stored in a desiccator until use [9]. 
Preparation of spray dried FB and solid dispersions of FB with 
HPMC and HPMCAS 
Spray dried FB was prepared to check if the process i.e. spray drying 
has any effect on the crystallinity of pure drug. FB was dissolved in 
methanol to form a 2% w/v solution. This solution was sonicated for 
5 min. to obtain a clear solution. It was subjected to spray drying 
(Lab Ultima, LU 228 Advanced, Mumbai), keeping the inlet 
temperature at 50 °C; outlet temperature 40 °C; feed pump flow rate 
3 ml/min; aspirator speed 65 m3/h, a vacuum of 90 mm/Hg and 
atomization pressure at 1.2 kg/cm2
 
. Solid dispersions of FB were 
also prepared in the following compositions by spray drying using 
the above-mentioned conditions (table 1) [9]. 
Table 1: Physical mixtures and spray dried solid dispersions composition 
  Spray dried solid dispersions composition 
FB: HPMC Ratio FB: HPMC Ratio 
PMC1 2:1 SD MC1 2:1 
PMC2 1:1 SD MC2 1:1 
PMC3 1:2 SD MC3 1:2 
FB: HPMCAS  FB: HPMCAS  
PM CAS4 2:1 SD CAS4 2:1 
PM CAS5 1:1 SD CAS5 1:1 
PM CAS6 1:2 SD CAS6 1:2 
 
Characterizations of physical mixtures and solid dispersions 
Optical and polarized microscopy 
Each sample (<0.1 mg) was mounted on a glass slide with a brush, 
covered with silicone oil and a coverslip and was observed under the 
microscope (Lecia DMLP, Germany). Light intensity was adjusted 
and observations were done under normal and polarized light (by 
engaging the polarizer). Birefringence patterns were observed at a 
high-resolution scale and images were acquired. 
FT-IR spectroscopic analysis 
FT-IR Spectrograms were obtained using FT-IR spectrometer (Perkin 
Elmer, USA) by the conventional KBr pellet method [9]. The samples 
were grounded gently with anhydrous KBr and compressed to form 
pellets and the scanning was carried out in a range of 4000-400 cm-1
DSC analysis 
.  
Each sample (2 mg) was scanned in an aluminum pan over the range 
of 20 °C to 220 °C, at a rate of 10 °C/min under the controlled 
environment of liquid nitrogen at a rate of 50 ml/min. Thermal data 
analysis of the DSC thermograms was conducted using TA Universal 
Analysis (DSC Q 20-2661 TA Instruments, USA). 
XRD analysis 
XRD measurements were performed using X-ray diffractometer 
(X'PERT PRO, PANalytical, Netherlands). Samples were irradiated 
with monochromatic Cu radiation and patterns were obtained by 
continuous scanning at a step size of 0.017 °, with detector 
resolution in 2θ (diffraction angle) between 3.5 ° to 50 θ. The 
generator settings used were 40 mA and intensity resolution of 
45kV at ambient temperature [10]. 
Scanning electron microscopy 
The electron microscopy analysis was carried out to study the 
surface morphology of optimized dispersions in a scanning electron 
microscope (Carl Zeiss SUPRA 55). Samples were gold coated and 
mounted on the stubs using double-sided carbon adhesive tape and 
were analyzed in different magnification scales at 100 kV ionizing 
radiations [11]. 
In vitro dissolution studies  
FB, spray dried FB, physical mixtures and solid dispersions 
equivalent to 54 mg of drug were subjected to in vitro dissolution 
testing using USP Type II (Paddle type) Dissolution Apparatus 
(Electrolab TDT-08l Dissolution Tester, India), using 900 ml of 
0.05M SLS as dissolution medium. The rotation speed of paddle was 
kept at 50 rpm and the temperature was set at 37±2 °C. Samples (5 
ml) were withdrawn at intervals of 5, 10, 15, 30, 45, 60, 90, 120 min. 
and were replaced with an equal amount of dissolution medium to 
reimburse the loss during sampling After each withdrawal, aliquots 
were filtered through a 0.2 µm membrane filter (Millipore, India) 
and analyzed using optimized HPLC method [10, 11]. 
Calculation of dissolution parameters 
Percent Dissolution Efficiency (DE) for each formulation was computed 
as the percent ratio of an area under the dissolution curve up to the time, 
t, to that of the area of the rectangle described by 100% dissolution at 




�  100 − − − − − − − − − − − − − 1 
Where y is the percent drug dissolved at time t. For these 
formulations, DE30 and DE60 were calculated. Other dissolution 
parameters such as t60, DP5, DP30, and DP120 were also calculated (t60 
RESULTS AND DISCUSSION 
is the time taken to release 60% of the drug and DP is the percent 
drug released at a particular time). 
Solubility determination in different media 
Results from saturation solubility studies demonstrated that there 
was no significant difference between saturation solubility values of 
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FB at different pH. This is attributed to the fact that it has no 
ionizable group, so its solubility is not influenced by a change in pH. 
The solubility of FB increased significantly in 25 mmol SLS and 0.05 
M SLS solutions which might be attributed to its micellar 
solubilization property [12]. The solubility data in various media are 
given in fig. 1. 
  
 
Fig. 1: Saturation solubility of FB in different media (mean±SD, n=3) 
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Fig. 2: Optical micrographs of (a1) FB (b1) Spray-dried FB (c1) HPMC physical mixture (d1) HPMC solid dispersion (e1) HPMCAS physical 
mixture (f1) HPMCAS solid dispersion. Polarized micrographs of (a2) FB (b2) Spray-dried FB (c2) HPMC physical mixture (d2) HPMC solid 
dispersion (e2) HPMCAS physical mixture (f2) HPMCAS solid dispersion 
 
Characterizations of FB, spray dried FB, HPMC, HPMCAS, 
physical mixtures and solid dispersions 
Optical and polarized microscopy 
Optical and polarized microscopy was done to observe the 
birefringence pattern. Fig. 2 showed optical and polarized 
micrographs of the drug, polymeric carriers, physical mixtures and 
solid dispersions. Presence of birefringence confirms the presence of 
crystallinity in the samples. However, loss of crystallinity was 
observed in prepared physical mixtures and solid dispersions by 
uniform dispersion of the drug in molecular matrix. This phenomenon 
suggested effective encapsulation of FB into the hydrophilic matrix of 
HPMC and HPMCAS with no evidence of FB crystals on the surface. 
FT-IR spectroscopic analysis 
The IR spectrum provides information about the chemical bonds, 
characteristics functional group and usually detects interactions 
between drug and carrier in the solid dispersion. The spectrum 
overlay plot of the drug, polymers, physical mixtures and optimized 
solid dispersions are depicted in fig. 3. The IR spectrum of the drug 
showed major peaks at various C-H stretches from 2872 cm-1 to 
3068 cm-1. The C=C stretches were observed at 1594 cm-1 and the 
bands at 1173 cm-1 and 1291 cm-1 were attributed to C-O stretches. 
The spectra for the raw and spray-dried drug were similar, 
confirming that the drug did not undergo any transformation after 
spray drying [5]. The IR spectra of the solid dispersion and the 
physical mixture of the drug with HPMC and HPMCAS clearly 
showed that there is no incompatibility of the drug with the 
polymer. No significant shifts were observed in the IR spectrum of 
the solid dispersion and all the stretching as well as bending 
vibrations such as OH stretch, C-H stretches, C-O stretch, C=C 
stretch, C-H bending, C-Cl stretches were observed. These findings 
observed negligible chemical interaction between drug and 
polymers and successfully be transformed into an effective 
pharmaceutical dosage form. 
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Fig. 3: FT-IR spectrographs of (a) FB (b) Spray dried FB (c) HPMC (d) HPMC physical mixture (e) HPMC solid dispersion (f) HPMCAS (g) 
HPMCAS Physical Mixture (h) HPMCAS solid dispersion 
 
DSC analysis 
Melting endotherms of FB and spray dried FB were observed at 
around 81.56 °C and 82.24 °C, respectively, confirming its crystalline 
state with no major effect of spray drying on endotherm shifting. Glass 
transition temperature of HPMC and HPMCAS were observed at 
around 170 °C and 120 °C, respectively. The physical mixtures of FB 
with different polymers, with the melting endotherms at 82.23 °C and 
81.63 °C, confirmed the residual crystallinity due to the homogenous 
mixture formed (fig. 4). Furthermore, broad endothermic peaks in 
these mixtures could be attributed to the absence of endothermic 
relaxation [13]. Solid dispersions presented with no incidence of 
crystallinity, indicating perfect miscibility of drug and polymer to form 
stable solid dispersion for oral delivery [14]. 
 
 
Fig. 4: DSC thermograms of (a) FB (b) Spray-dried FB (c) HPMC (d) HPMC physical mixture (e) HPMC solid dispersion (f) HPMCAS (g) 
HPMCAS Physical Mixture (h) HPMCAS solid dispersion 
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In the XRD of FB and spray-dried FB, sharp peaks were observed at a 
diffraction angle (2θ) of 12.03 °, 14.49 °, 15.81 °, 16.31 °, 16.77 °, 
17.97 °, 19.37 °, 20.68 °, 20.94 °, 21.71 °, 21.89 ° and 22.33 °, 
indicating its crystalline nature and reduction of crystallinity was 
observed in spray-dried drug [15]. Partial amorphization was 
observed in the physical mixture, whereas, optimized solid 
dispersions observed with a reduction in the crystallinity index with 
an absence of diffraction patters indicating a change in overall 
geometry of crystalline to amorphous form and suggesting effective 
molecular dispersion of FB in solid dispersion formulation (fig. 5).  
This phenomenon may be attributed to the attainment of molecular 
dispersion state in these formulations and confirmed the amorphous 
transformation of drug FB in the solid dispersions [15]. 
 
 
Fig. 5 (a): XRD patterns of (a) FB (b) spray-dried FB (c) HPMC (d) HPMC physical mixture (e) HPMC solid dispersion (f) HPMCAS (g) 
HPMCAS physical mixture (h) HPMCAS solid dispersion 
 
Scanning electron microscopy 
The particles of amorphous dispersions in SEM seemed to be 
collapsed and spherical in shape due to the rapid evaporation of 
solvent during spray drying (fig. 6). The size and morphology of 
spray dried amorphous solid dispersions confirms a similar surface 
state for solid dispersions of both the polymers, negotiating the 
effect of surface state on the dissolution rate [16]. 
 
 
(a)     (b) 
Fig. 6: SEM of (a) HPMC solid dispersion (b) HPMCAS solid dispersion 
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In vitro dissolution studies 
The in vitro release profile of FB, physical mixtures and optimized 
formulation in 0.05 M SLS is shown in fig. 7 and 8, respectively. A 
low release rate of 16.31 % of pure drug indicated the need for 
enhancing the dissolution regime in order to develop a successful 
drug product. However, the presence of polymers significantly 
increased the dissolution of FB from the physical mixtures, i.e. PMC 
1, PMC 2, PMC 3 containing HPMC and PM CAS 1, PM CAS 2 and PM 
CAS 3 containing HPMCAS. For HPMC, the rate of dissolution was 
found to be highest in the physical mixture PMC 3 i.e. 57.13% in 2 h. 
In the case of HPMCAS, the percentage cumulative drug released 
(%CDR) was highest in PM CAS 3 i.e. 62.84% in 2 h. This suggests 
that HPMCAS has a significant effect on the solubilisation of the drug 
as compared to HPMC in the formulation [16]. Moreover, it was 
observed that the dissolution of the drug from its carrier first 
increases and then it gets stable after some time, indicating the 
solubilizing effect of both the polymers [17, 18]. This enhancement 
of dissolution of FB from HPMCAS can be described by several 
factors viz. lack of crystallinity, i.e., amorphization, increased 
wettability and dispersibility, and particle size reduction [19-21]. 
Also, prevention of aggregation during dissolution and particle size 
reduction could also be attributed to a better dissolution profile. 
Overall, HPMCAS showed better augmentation in dissolution rate 




Fig. 7: Dissolution curves of FB, spray dried FB, physical mixtures and prepared solid dispersions of FB with HPMC (mean±SD, n=3) 
(P<0.05, compared PMC 1-PMC 3 with pure Fb) (P<0.001, compared SD MC 1-SD MC 3 with pure FB) 
 
 
Fig. 8: Dissolution curves of FB, spray dried FB, physical mixtures and prepared solid dispersions prepared with HPMC and HPMCAS 
(mean±SD, n=3) (P<0.05, compared PM CAS1-PM CAS 3 with pure FB) (P<0.001, compared SD CAS 1-SD CAS 3 with pure FB) 
 
Dissolution parameters of solid dispersions of FB with HPMC 
and HPMCAS 
The values for various dissolution parameters calculated for six 
solid dispersions prepared by using the different drug to polymer 
ratios are shown in table 2. It was evident that HPMCAS enhanced 
the dissolution rate of the drug to a greater extent. HPMCAS 
dissolution curve shoots up quickly than HPMC dissolution curve 
and was better at initiation and maintenance of supersaturation. It 
can be seen that solid dispersions SD3 and SD6 showed best 
results i.e. have the highest values for DE 60
 
 for HPMC and 
HPMCAS, respectively [22]. 
Table 2: Dissolution parameters of solid dispersions 
Solid dispersion batches DE DE30  DP60 DP5 DP30 t120 60(min) 
SD MC 1 39.40 % 44.83 % 23.26 % 51.48 % 56.14 % - 
SD MC 2 52.41 % 64.90 % 35.21 % 72.65 % 82.94 % 15.75 
SD MC 3 55.54 % 68.66 % 39.23 % 75.29 % 90.82 % 13.14 
SD CAS 1 41.14 % 51.49 % 24.52 % 59.27 % 69.24 % 34.98 
SD CAS 2 56.32 % 70.33 % 36.12 % 79.09 % 90.72 % 12.87 
SD CAS 3 73.81 % 85.01 % 58.26 % 93.23 % 98.37 % 5.54 
Bedi et al. 




We focused on the comparison of HPMC and HPMCAS as the versatile 
hydrophilic polymers for the attainment of amorphization and 
enhancement of in vitro dissolution. The formed solid dispersion was 
in the amorphized state in the solid state characterizations and 
revealed highest in the release, particularly with HPMCAS based solid 
dispersion. Multi-folds augmentation in release behavior of optimized 
solid dispersions prepared with HPMCAS was observed and was 
statistically significant (p<0.05) as compared with the pure API. These 
studies revealed that even though the drug remains in amorphous 
form in solid dispersions based on both the polymers, HPMCAS based 
amorphous solid dispersions demonstrated improved dissolution 
profile as compared to HPMC based dispersions. 
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